Brent Satterfield - Net Worth and Insider Trading
Brent Satterfield Net Worth
The estimated net worth of Brent Satterfield is at least $3 Million dollars as of 2024-11-13. Brent Satterfield is the Chief Science Officer, 10% Owner of Co-Diagnostics Inc and owns about 2,275,000 shares of Co-Diagnostics Inc (CODX) stock worth over $3 Million. Details can be seen in Brent Satterfield's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brent Satterfield has not made any transactions after 2018-05-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Brent Satterfield
Brent Satterfield Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brent Satterfield owns 1 companies in total, including Co-Diagnostics Inc (CODX) .
Click here to see the complete history of Brent Satterfield’s form 4 insider trades.
Insider Ownership Summary of Brent Satterfield
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CODX | Co-Diagnostics Inc | 2018-05-11 | director & Chief Science Officer |
Brent Satterfield Latest Holdings Summary
Brent Satterfield currently owns a total of 1 stock. Brent Satterfield owns 2,275,000 shares of Co-Diagnostics Inc (CODX) as of May 11, 2018, with a value of $3 Million.
Latest Holdings of Brent Satterfield
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CODX | Co-Diagnostics Inc | 2018-05-11 | 2,275,000 | 1.13 | 2,569,613 |
Holding Weightings of Brent Satterfield
Brent Satterfield Form 4 Trading Tracker
According to the SEC Form 4 filings, Brent Satterfield has made a total of 0 transactions in Co-Diagnostics Inc (CODX) over the past 5 years. The most-recent trade in Co-Diagnostics Inc is the acquisition of 1,305 shares on May 11, 2018, which cost Brent Satterfield around $2,375.
Insider Trading History of Brent Satterfield
- 1
Brent Satterfield Trading Performance
GuruFocus tracks the stock performance after each of Brent Satterfield's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brent Satterfield is 91.21%. GuruFocus also compares Brent Satterfield's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brent Satterfield within 3 months outperforms 6 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Brent Satterfield's insider trading performs compared to the benchmark.
Performance of Brent Satterfield
Brent Satterfield Ownership Network
Ownership Network List of Brent Satterfield
Ownership Network Relation of Brent Satterfield
Brent Satterfield Owned Company Details
What does Co-Diagnostics Inc do?
Who are the key executives at Co-Diagnostics Inc?
Brent Satterfield is the director & Chief Science Officer of Co-Diagnostics Inc. Other key executives at Co-Diagnostics Inc include Chief Financial Officer Brian Lee Brown , director & CEO and President Dwight H Egan , and CFO and Secretary Reed L Benson .
Co-Diagnostics Inc (CODX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Co-Diagnostics Inc (CODX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Co-Diagnostics Inc (CODX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Co-Diagnostics Inc (CODX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Co-Diagnostics Inc Insider Transactions
Brent Satterfield Mailing Address
Above is the net worth, insider trading, and ownership report for Brent Satterfield. You might contact Brent Satterfield via mailing address: 4049 S. Highland Drive, Salt Lake City Ut 84124.